Lack of association between gestational age adjusted TSH percentiles and neurodevelopmental outcomes among preterm infants

J Neonatal Perinatal Med. 2022;15(2):243-247. doi: 10.3233/NPM-210910.

Abstract

Background: Limited evidence exists on whether subclinical hypothyroidism suggested by mildly elevated TSH levels affect neurodevelopment and growth in preterm infants. The objective of this study was to determine the association between gestational age adjusted TSH percentiles and neurodevelopmental outcomes among preterm infants.

Methods: Univariate linear regression analysis was conducted to determine, in infants born less than thirty-two weeks gestational age, the correlation between the TSH percentile on the last newborn screen and neurodevelopmental assessment scores and growth outcomes at eighteen to twenty-two months of corrected age.

Results: Seventy-four patients were enrolled in the study with a mean gestational age of 28.8 weeks. There was no correlation between the last TSH percentile value and Bayley-III cognitive composite score or other neurodevelopmental or growth outcomes.

Conclusion: In a cohort of preterm infants, higher TSH percentiles suggesting potential subclinical hypothyroidism did not predict any adverse effect on neurodevelopmental or growth outcomes.

Keywords: Neurodevelopment; TSH; preterm; subclinical hypothyroidism.

MeSH terms

  • Cohort Studies
  • Gestational Age
  • Humans
  • Hypothyroidism* / diagnosis
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Neurodevelopmental Disorders* / diagnosis
  • Thyrotropin

Substances

  • Thyrotropin